I noticed another company also working on RP. Last update seemed to be a year ago so nit sure how they are progressing now.
https://www.gensight-biologics.com/2020/04/14/gensight-biologics-announces-positive-data-safety-monitoring-board-review-of-pioneer-phase-i-ii-trial-of-gs030-combining-gene-therapy-and-optogenetics-for-the-treatment-of-retinitis-pigmentosa/
Could this be relevant to us?, page-10
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $933.2M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $958.2K | 4.847M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 334614 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 379756 | 5 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |